Documentos de Grivas P.D. | REDI

Regresar

Mostrando 2 resultados de: 2

Filtros aplicados

Área de conocimiento: "Cáncer"

Subtipo de publicación

Publisher

Journal of Clinical Investigation(1)

Journal of Urology(1)

Área temáticas

Enfermedades(2)

Área de conocimiento

Medicina interna(1)

Año de Publicación

Origen

Palabras Claves

drug administration schedule(1)

neoadjuvant therapy(1)

urinary bladder neoplasms(1)

HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer

Abstract: BACKGROUND. A common germline variant in HSD3B1(1245A>C) encodes for a hyperactive 3β-hydroxysteroid

Palabras claves:

Almassi N., Alyamani M., Berk M.P., Chien C., Emamekhoo H., Figg W.D., Garcia J., Grivas P.D., Hu B., Hwang T.H., Koshkin V.S., Mendiratta P., Park S., Peer C.J., Richard J. Auchus, Rini B., Sharifi N., Taylor J., Tyler A., Upadhyay S.K.

Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer

Abstract: Purpose:We investigated the pathological response rates and survival associated with 3 vs 4 cycles o

Palabras claves:

drug administration schedule, neoadjuvant therapy, Survival, urinary bladder neoplasms

Barocas D.A., Bivalacqua T.J., Black P.C., Cookson M.S., Dall'Era M.A., Daneshmand S., Di Trapani E., Diego M. Carrión, Dinney C.P., D’Andrea D., Grivas P.D., Holzbeierlein J.M., Kassouf W., Lotan Y., McGrath J.S., Montgomery J.S., North S., Shariat S.F., Soria F., Spiess P.E., Sridhar S.S., Stephenson A.J., Thorpe A.C., van Rhijn B.W.G., Wright J.L., Zargar H.